Loprinzi, C L <br/><br/>
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.  [electronic resource] 

 -  Oncology  Oct 1994 
 - 2-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0030-2414 
<br/><br/><label>Standard No.: </label>10.1159/000227407  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anorexia--drug therapy<br/>Appetite--drug effects<br/>Cachexia--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Megestrol--administration & dosage<br/>Megestrol Acetate<br/>Middle Aged<br/>Paraneoplastic Syndromes--drug therapy<br/>Prospective Studies<br/>Surveys and Questionnaires<br/>Survival Rate<br/>Time Factors<br/>Weight Gain